Scientists have discovered two genetic programs that are responsible for taking blank-slate stem cells to turn them into both red and white cells that make up human blood.
Igor Slukvin, the lead researcher from University of Wisconsin-Madison explained that this was the first demonstration of the production of different kinds of cells from human pluripotent stem cells, using transcription factors.
Slukvin said that by over-expressing just two transcription factors, they could reproduce the sequence of events they see in the "embryo" where blood was made, in the laboratory dish.
The method developed by Slukvin's group was shown to produce blood cells in abundance. For every million stem cells, the researchers were able to produce 30 million blood cells.
According to Slukvin, an unfulfilled aspiration is to produce hematopoietic stem cells, multipotent stem cells found in bone marrow that are used to treat some cancers, including leukemia and multiple myeloma, in the lab.
The study is published in the journal Nature Communications.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
